| Id.No.29310 | |
| HEPATO-PROTECTIVE EFFECT OF TRIPHALA IN INFECTIVE HEPATITIS (HEPATITIS B): A CLINICAL AND AN EXPERIMENTAL STUDY | |
| *N. Sujata **Sujeet Kumar **Gopal Das Gupta *** Rai. N. P. | |
| Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi. | |
| Abstract: “Are we sitting at the Volcano? Time to wakeup.” Liver is the hub of wheel of life. Liver is one of the extensively explored areas in Modern Medicine. Among the various diseases affecting it, Hepatitis-B virus infection is the most common cause. The clinical symptoms of Hepatitis-B are similar with those described under Kamala Roga in Ayurveda. Hepatitis-B, because of its potential to cause life-threatening complications like Cirrhosis, Ascites, and Hepatocellular Carcinoma, has been kept on the top of National Agenda in Public Health Administration. Hepatitis-B virus infects more than 2 billion people worldwide, out of which 360 millions are chronic carriers annually1. It is the 10th leading cause of mortality and Hepatocellular Carcinoma is the 5th most common cancer in the world which accounts for 1.2 millions deaths globally every year2. Western Medicine, despite its enormous success does not offer any promising cure and here the role of traditional systems of medicine cannot be overlooked. Ayurveda, the ancient science of life is enriched with ample amount of herbal drugs, which are tested and trusted and subjected to thorough clinical and experimental studies. The drugs have been proved safe and highly efficacious with almost no side effects and have been included in Pub-Med India and National Index of Medicine. A trial has been conducted as part of research program to evaluate the role and efficacy of Triphala in the management of Hepatitis-B. Total 44 cases of Hepatitis-B were registered, out of which 38 cases completed the treatment schedule .The result of treatment were found satisfactory in terms of clinical and biochemical parameters. Moreover, Experimental Study has also been carried to substantiate the above clinical findings and also evaluate the mode of action of trial drug. | |
| Key words: Kamala, Jaundice, Hepatitis B, LFTs, Hepatoprotective, Antioxidant, M.D.A., and S.O.D. | |
| * Senior Resident, Dept. of Kayachikitsa ** Junior Resident, Dept. of Kayachikitsa *** Professor & Head, Dept. of Kayachikitsa. |
This post has been viewed 30 times.